KOMBIGLYZE XR 5MG/1000MG TABLET (Saxagliptin Metformin) Guide
KOMBIGLYZE XR 5MG/1000MG TABLET contains Saxagliptin 5mg and Metformin XR 1000mg, a combination antidiabetic medicine prescribed to improve blood glucose control in Type 2 Diabetes.
KOMBIGLYZE XR 5MG/1000MG TABLET
KOMBIGLYZE XR 5MG/1000MG TABLET (Saxagliptin 5mg + Metformin XR 1000mg): Comprehensive Guide and Benefits
Introduction to KOMBIGLYZE XR 5MG/1000MG TABLET
KOMBIGLYZE XR 5MG/1000MG TABLET: DPP-4 Inhibitor + Biguanide Combination Antidiabetic Medicine
KOMBIGLYZE XR 5MG/1000MG TABLET is a prescription Diabetes Medication containing Saxagliptin 5mg and Metformin Hydrochloride Extended Release 1000mg. It belongs to the drug class Dipeptidyl Peptidase-4 (DPP-4) Inhibitor + Biguanide Combination Therapy and is prescribed along with diet and exercise to improve blood sugar control in adults with Type 2 Diabetes Mellitus when treatment with both medicines is appropriate. (1mg)
This extended-release combination provides dual-action glucose management. Saxagliptin helps regulate insulin secretion through incretin hormone activity, while Metformin XR helps reduce glucose production in the liver and improves insulin sensitivity. (Drugs.com)
Key Benefits of KOMBIGLYZE XR 5MG/1000MG TABLET
Helps improve blood glucose control in adults with Type 2 Diabetes Mellitus.
Supports better fasting and post-meal glucose management.
Enhances glucose-dependent insulin release through incretin pathway support.
Helps reduce excess glucose production by the liver.
Provides convenient once-daily combination therapy when prescribed. (Drugs.com)
How KOMBIGLYZE XR 5MG/1000MG TABLET Works
KOMBIGLYZE XR 5MG/1000MG TABLET contains two active components with complementary mechanisms:
Saxagliptin:
Saxagliptin inhibits the enzyme Dipeptidyl Peptidase-4 (DPP-4), which normally breaks down incretin hormones such as GLP-1 and GIP. By increasing incretin activity, it helps improve glucose-dependent insulin release and reduces glucagon secretion.
Metformin Hydrochloride Extended Release:
Metformin belongs to the Biguanide class. It works mainly by reducing glucose production in the liver, improving insulin sensitivity, and supporting better utilisation of glucose by body tissues.
Together, these actions help maintain improved blood glucose levels in eligible patients with Type 2 Diabetes.
Usage Instructions for KOMBIGLYZE XR 5MG/1000MG TABLET
Take KOMBIGLYZE XR 5MG/1000MG TABLET exactly as prescribed by your doctor.
Usually taken once daily with food, commonly with the evening meal, as directed by the healthcare provider. (Drugs.com)
Swallow the extended-release tablet whole with water.
Do not crush, chew, or split the tablet.
Monitor blood glucose levels regularly as advised.
Do not change the dose or discontinue treatment without medical guidance.
Medicinal Advantages of KOMBIGLYZE XR 5MG/1000MG TABLET
Provides dual-mechanism blood glucose regulation.
Supports improved insulin response after meals.
Helps control excessive glucose production from the liver.
Offers an extended-release formulation for sustained Metformin action.
Supports personalised diabetes management plans under medical supervision.
NOTE: KOMBIGLYZE XR 5MG/1000MG TABLET is a prescription-only medicine. It should be used under healthcare supervision with appropriate monitoring, especially of kidney function and blood glucose levels. (Apollo Pharmacy)
Off-Label Uses of KOMBIGLYZE XR 5MG/1000MG TABLET
Saxagliptin and Metformin combinations may occasionally be evaluated for uses outside approved indications based on specialist assessment and available clinical evidence.
Physician-guided metabolic management approaches.
Specialist-directed treatment strategies involving insulin resistance.
Individualised glucose management plans.
Disclaimer: Off-label use should only be considered under qualified medical supervision.
Expert Advice for Optimal Use
Follow your prescribed dosing schedule consistently.
Maintain a balanced diet and regular physical activity as recommended.
Monitor blood sugar levels according to your diabetes care plan.
Inform your doctor about kidney problems or other medical conditions.
Keep regular diabetes follow-up appointments.
Avoid self-adjusting the medication dose.
Precautions
Cardiovascular Health
Patients with heart conditions should inform their doctor before starting treatment. Regular medical evaluation may be recommended depending on individual health status.
Liver & Kidney Function
Kidney function assessment is important because Metformin clearance depends on kidney health. Patients with kidney impairment should consult their healthcare provider before use. (ACSQHC)
Pregnancy & Breastfeeding
Pregnant or breastfeeding women should use KOMBIGLYZE XR 5MG/1000MG TABLET only after consultation with a healthcare professional.
Drug Interactions
Inform your doctor about all medicines, supplements, and diabetes treatments being used, especially medicines that may affect blood sugar levels or kidney function.
Existing Medical Conditions
Patients with kidney disease, metabolic disorders, dehydration, severe infections, or a history of pancreatic problems should discuss their medical history before starting treatment.
Storage Instructions
Store below 30°C in a dry place. (1mg)
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Do not use after the expiry date mentioned on the pack.
Frequently Asked Questions (FAQs)
Q: What is KOMBIGLYZE XR 5MG/1000MG TABLET used for?
A: It is prescribed to improve blood sugar control in adults with Type 2 Diabetes Mellitus along with diet and exercise. (NPRA)
Q: What are the active ingredients in KOMBIGLYZE XR 5MG/1000MG TABLET?
A: It contains Saxagliptin 5mg and Metformin Hydrochloride Extended Release 1000mg. (Drugs.com)
Q: What type of medicine is KOMBIGLYZE XR 5MG/1000MG TABLET?
A: It is a combination antidiabetic medicine containing a DPP-4 inhibitor and a Biguanide.
Q: How does KOMBIGLYZE XR 5MG/1000MG TABLET work?
A: Saxagliptin improves incretin hormone activity, while Metformin reduces liver glucose production and improves insulin sensitivity.
Q: Can KOMBIGLYZE XR 5MG/1000MG TABLET be stopped suddenly?
A: Do not stop this medicine without consulting your doctor, as blood sugar control may worsen.
Q: Is KOMBIGLYZE XR 5MG/1000MG TABLET an extended-release medicine?
A: Yes. It contains Metformin Hydrochloride Extended Release, designed for gradual medicine release. (Drugs.com)
Product Tags
KOMBIGLYZE XR 5MG/1000MG TABLET, KOMBIGLYZE XR TABLET, Saxagliptin 5mg, Metformin XR 1000mg, Saxagliptin Metformin tablet, DPP-4 inhibitor medicine, Biguanide antidiabetic medicine, Type 2 diabetes medicine, blood sugar control tablet, extended release diabetes tablet, oral antidiabetic medicine, AstraZeneca KOMBIGLYZE XR, prescription diabetes medication, diabetes management therapy, glucose lowering medicine, insulin sensitivity medicine, diabetic care tablet, metabolic health medicine, glycemic control therapy.
